Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Non-small Cell Lung Cancer Metastatic × tusamitamab ravtansine × 1 year × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Non-small Cell Lung Cancer Metastatic 2 Neoplasms 2 Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) 1 Non-squamous Non-small Cell Lung Cancer 1 Breast Cancer Metastatic 1 Adenocarcinoma Gastric 1

Interventions

tusamitamab ravtansine 2 pembrolizumab 1 dacomitinib 1 Ramucirumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04154956 2025-08-05

CARMEN-LC03

Sanofi

Phase 3 Active not recruiting

389 enrolled 16 charts

Non-small Cell Lung Cancer Metastatic

NCT04394624 2025-06-06

CARMEN-LC04

Sanofi

Phase 2 Terminated

31 enrolled 22 charts

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡